Latest News in the pharma Industry

Research & Development

Takeda announces EMA acceptance of ixazomib's MAA for patients with relapsed/refractory multiple myeloma

Takeda announces EMA acceptance of ixazomib's MAA for patients with relapsed/refractory multiple myeloma

24 Aug 2015

Read more 
Alkermes provides update on FDA review of Aristada for the treatment of schizophrenia

Alkermes provides update on FDA review of Aristada for the treatment of schizophrenia

24 Aug 2015

Read more 
Jardiance demonstrated cardiovascular risk reduction in people with type 2 diabetes at high risk for CV events

Jardiance demonstrated cardiovascular risk reduction in people with type 2 diabetes at high risk for CV events

21 Aug 2015

Read more 
Presage Biosciences Receives Strategic Investment from Takeda

Presage Biosciences Receives Strategic Investment from Takeda

20 Aug 2015

Read more 
Bavarian Nordic Initiates Phase I Clinical Trial of MVA-BN in Respiratory Syncitial Virus

Bavarian Nordic Initiates Phase I Clinical Trial of MVA-BN in Respiratory Syncitial Virus

19 Aug 2015

Read more 
New Data Show Stiolto Respimat Provides Clinically Meaningful Improvements in COPD Health-Related Quality of Life Measure

New Data Show Stiolto Respimat Provides Clinically Meaningful Improvements in COPD Health-Related Quality of Life Measure

18 Aug 2015

Read more 
FDA Accepts sBLA for Keytruda, Merck’s Anti-PD-1 Therapy, for First-Line Treatment of Advanced Melanoma, and Grants Priority Review

FDA Accepts sBLA for Keytruda, Merck’s Anti-PD-1 Therapy, for First-Line Treatment of Advanced Melanoma, and Grants Priority Review

18 Aug 2015

Read more 
Results from B-YOND Extension Study Reinforce Long-Term Clinical Profile of Alprolix for the Treatment of Hemophilia B

Results from B-YOND Extension Study Reinforce Long-Term Clinical Profile of Alprolix for the Treatment of Hemophilia B

17 Aug 2015

Read more 
Pivotal Phase II Study Showed Roche's Investigational Immunotherapy Atezolizumab Shrank Tumours in People With a Specific Type of Lung Cancer

Pivotal Phase II Study Showed Roche's Investigational Immunotherapy Atezolizumab Shrank Tumours in People With a Specific Type of Lung Cancer

17 Aug 2015

Read more 
Kite Pharma Provides Update on KTE-C19 Clinical Trial

Kite Pharma Provides Update on KTE-C19 Clinical Trial

17 Aug 2015

Read more 
Drug Discovery Benefits from Evaporative Crystallisation Technology

Drug Discovery Benefits from Evaporative Crystallisation Technology

14 Aug 2015

Read more 
FDA Extends Action Date for sBLA Application for Opdivo in Previously Untreated Advanced Melanoma

FDA Extends Action Date for sBLA Application for Opdivo in Previously Untreated Advanced Melanoma

13 Aug 2015

Read more